Filing Details

Accession Number:
0001179110-12-002554
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-14 17:36:49
Reporting Period:
2012-02-13
Filing Date:
2012-02-14
Accepted Time:
2012-02-14 17:36:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1441438 James Bramble 3838 West Parkway Blvd.
Salt Lake City UT 84120
Chief Legal Officer And Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-13 5,172 $26.06 5,172 No 4 M Direct
Common Stock Disposition 2012-02-13 5,172 $37.96 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2012-02-13 16,500 $0.00 16,500 $26.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,000 2009-07-21 2014-01-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 518 Indirect 401(k)
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.
  2. Between January 1, 2011 and December 31, 2011, the reporting person acquired 35 shares of USANA common stock in transactions pursuant to the issuer's 401(k) plan.